CONTINUATION H&S, page-7

First 7 Last

Share
Profile

Follow
jayneen

1,206 Posts.

270

22/07/20

14:25

Post #: 46029045
Share

Originally posted by YLJ: ↑

Interesting series of patterns on RSG since the formation of the H&S top formed July-Sep 2019
(not shown on chart). It subsequently formed a bearish Continuation H&S at the target level
and proceeded to it's low in mid-March this year.
It has since formed and broken out from what can be viewed as either a H&S bottom or an
Ascending Triangle (if you do not like the asymmetrical look of the H&S).
The breakout on 14 May was stopped short and has formed a bullish Continuation H&S
with a breakout last Wednesday (July 1st).
The subsequent retest of the neckline slightly penetrated it, but not enough to hit a
properly placed stop.
I did not see or take that trade (& probably would not have) but I have taken an entry
this morning with a tight stop placed below the swing low, (one of the advantages trading a retest).
Will see how it behaves and will likely cut it if it mucks around for too long, but
worth a shot IMHO.

Dotted blue lines are the measured targets, the higher being that of the H&S/Ascending
Triangle and the lower that of the Continuation H&S.

GLTA

Expand

Amazing!

Your dotted blue line target is bang on.

Well done.

Originally posted by YLJ: ↑

Interesting series of patterns on RSG since the formation of the H&S top formed July-Sep 2019
(not shown on chart). It subsequently formed a bearish Continuation H&S at the target level
and proceeded to it's low in mid-March this year.
It has since formed and broken out from what can be viewed as either a H&S bottom or an
Ascending Triangle (if you do not like the asymmetrical look of the H&S).
The breakout on 14 May was stopped short and has formed a bullish Continuation H&S
with a breakout last Wednesday (July 1st).
The subsequent retest of the neckline slightly penetrated it, but not enough to hit a
properly placed stop.
I did not see or take that trade (& probably would not have) but I have taken an entry
this morning with a tight stop placed below the swing low, (one of the advantages trading a retest).
Will see how it behaves and will likely cut it if it mucks around for too long, but
worth a shot IMHO.

Dotted blue lines are the measured targets, the higher being that of the H&S/Ascending
Triangle and the lower that of the Continuation H&S.

GLTA

Expand

RSG Price at posting: $1.39 Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 1 more message in this thread...

First 7 Last

Add RSG (ASX) to my watchlist

(20min delay)
Last 70.5¢		Change -0.005(0.70%)		Mkt cap ! $1.500B

Open	High	Low	Value	Volume
70.0¢	71.0¢	69.0¢	$9.005M	12.87M

Buyers (Bids)

No.	Vol.	Price($)
2	151500	70.0¢

Sellers (Offers)

Price($)	Vol.	No.
70.5¢	99995	1

View Market Depth

No.	Vol.	Price($)
1	144000	0.700
1	5500	0.695
13	315905	0.690
9	230611	0.685
18	304195	0.680

Price($)	Vol.	No.
0.710	50000	1
0.715	111762	4
0.720	198762	3
0.725	58223	2
0.730	97294	3

Last trade - 16.10pm 04/10/2024 (20 minute delay)

RSG (ASX) Chart

CONTINUATION H&S, page-7

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

CONTINUATION H&S, page-7

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News